학술논문
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Document Type
Artikel
Author
Davies, C; Pan, HC; Godwin, J; Gray, R; Arriagada, R; Raina, V; Abraham, M; Alencar, VHM; Badran, A; Bonfill, X; Bradbury, J; Clarke, M; Collins, R; Davis, SR; Delmestri, A; Forbes, JF; Haddad, P; Hou, MF; Inbar, M; Khaled, H; Kielanowska, J; Kwan, WH; Mathew, BS; Mittra, I; Muller, B; Nicolucci, A; Peralta, O; Pernas, F; Petruzelka, L; Pienkowski, T; Radhika, R; Rajan, B; Rubach, MT; Tort, S; Urrutia, G; Valentini, M; Wang, YC; Peto, R
Source
Lancet (London, England). 381(9869):805-816
Subject
Language
English
English
English
ISSN
1474-547X